The 18th European Symposium on Quantitative Structure–Activity Relationships

  title={The 18th European Symposium on Quantitative Structure–Activity Relationships},
  author={Anna Tsantili-Kakoulidou and Dimitris K. Agrafiotis},
  journal={Expert Opinion on Drug Discovery},
  pages={453 - 456}
The 18th European Symposium on Quantitative Structure–Activity Relationships (QSAR) took place in Rhodes, Greece, on 19 – 24 September 2010. It was organized by the Hellenic Society of Medicinal Chemistry and the Cheminformatics and QSAR Society, and co-sponsored by the European Federation of Medicinal Chemistry. The conference was thematically dedicated to discovery informatics and drug design and addressed the impact of informatics in all its variants (chemoinformatics, bioinformatics… 
2 Citations
QSAR/QSPR Modeling in the Design of Drug Candidates with Balanced Pharmacodynamic and Pharmacokinetic Properties
In this chapter, some historical aspects and a background overview for constructing Quantitative Structure-Activity Relationships (QSAR) and Quantitative structure-Property Relationship (QSPR) are provided.
The QSAR Paradigm to Explore and Predict Aquatic Toxicity


The expanding role of quantitative structure-activity relationships (QSAR) in toxicology.
Drug Metabolism for the Perplexed Medicinal Chemist
  • B. Testa
  • Biology
    Chemistry & biodiversity
  • 2009
The toxicological consequences of metabolism at the molecular, macromolecular, and macroscopic levels are manyfold and a brief overview is offered together with a summary of the reactions of toxification and detoxification of the antiepileptic valproic acid.
Pharmacophores in Drug Research
  • T. Langer
  • Chemistry, Biology
    Molecular informatics
  • 2010
The pharmacophore concept in modern drug research is highlighted and the most important use examples and success stories are reviewed. These include papers from method development as well as from
SAR maps: a new SAR visualization technique for medicinal chemists.
We present structure-activity relationship (SAR) maps, a new, intuitive method for visualizing SARs targeted specifically at medicinal chemists. The method renders an R-group decomposition of a
Improving compound quality through in vitro and in silico physicochemical profiling.
Current physicochemical in vitro assays and in silico predictions to support compound and library design through to lead optimization and key ADMET properties such as absorption, cell penetration, access to the brain, volume of distribution, plasma protein binding, metabolism, and toxicity are reviewed.
Can we estimate the accuracy of ADME-Tox predictions?
A Novel Multilevel Statistical Method for the Study of the Relationships between Multireceptorial Binding Affinity Profiles and In Vivo Endpoints
A novel method based on the sequential building of linked multivariate statistical models for drug research to overcome the traditional one-target assumption and to link in vivo endpoints with drug binding profiles, involving multiple receptors.
Enhanced SAR Maps: Expanding the Data Rendering Capabilities of a Popular Medicinal Chemistry Tool
An enhanced version of SAR maps is described that greatly expands the types of visualizations that can be displayed inside the cells, allowing the medicinal chemist to interactively analyze complex scaffolds with multiple substitution sites, correlate substituent structure and biological activity at multiple simultaneous dimensions, identify missing analogs or screening data, and produce information-dense visualizations for presentations and publications.
Scaffold explorer: an interactive tool for organizing and mining structure-activity data spanning multiple chemotypes.
The utility of the new tool rests on its interactivity and ability to accommodate the medicinal chemists' intuition by allowing the use of arbitrary substructures containing variable atoms, bonds, and/or substituents such as those employed in substructure search.